Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Testosterone Pretreatment in Poor Responders for IVF
NCT01961336Phase 3Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Oct 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Testosterone TEPI patch in poor ovarian response (POR) (2 arms), sponsored by Aristotle University of Thessaloniki. Primary endpoint: Total number of retrieved oocytes. Started Oct 2013; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT01961336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961336.